Otoacoustic Emissions Test: What You Need To Know

Our ears produce tiny, nearly imperceptible echoes every time they respond to sound. These echoes are like a hidden conversation happening inside the cochlea, and they reveal whether the inner ear is healthy and working as it should. These subtle signals mainly help those who cannot communicate what they hear, such as newborns and young children. This is when an objective test becomes essential, one that doesn’t rely on hand-raising, button-pressing, or verbal feedback.

This test, specifically called the Otoacoustic Emissions (OAE) test, is a quick procedure used to assess inner ear (cochlear) function. It measures faint “echoes” generated by the outer hair cells in response to sound. It’s non-invasive, painless, and completed in minutes. Thus, it has become a standard tool in newborn hearing screening and a valuable test for detecting early signs of hearing loss or ototoxicity (drug-induced damage to the ear).

Throughout this guide, we’ll walk through how the test works, the different types, and what the results mean. We’ll also explain why OAE testing remains a core component of modern hearing healthcare and determine if further testing or intervention, such as hearing aids in Toronto, Canada, are needed.

What Is an Otoacoustic Emissions Test?

An Otoacoustic Emissions test measures whether the inner ear is responding to sound normally. When the cochlea hears a sound, its outer hair cells vibrate and create a soft acoustic signal that travels back out into the ear canal. A sensitive probe detects and records this emission. If present, it usually indicates healthy cochlear function; if absent or reduced, further evaluation may be needed.

This makes OAE testing useful not only for identifying potential hearing loss, but also for confirming normal hearing, especially in groups who cannot reliably participate in standard hearing tests. This includes newborns, children, and even populations who can’t respond behaviorally, such as ICU patients in this 2025 study.

From a clinical standpoint, OAEs provide insight into the peripheral auditory system, particularly the cochlea. They don’t assess the auditory nerve or brain pathways, but they serve as a strong initial screening tool. If results are absent or inconsistent, audiologists typically follow up with further diagnostic tests such as tympanometry or auditory brainstem response (ABR).

How an OAE Test Works

The procedure is straightforward. A small probe containing a speaker and microphone is placed gently inside the ear canal. The probe plays soft clicking sounds or tones into the ear. If the cochlea’s outer hair cells are functioning well, they produce a measurable echo-like sound. The built-in microphone records this emission, and the software analyzes whether it falls within a normal range.

No response is required from the patient. They simply rest quietly during the test. This objectivity is why OAE screening is widely used in newborns and hard-to-test populations. The entire process usually takes 5–15 minutes, depending on the environment and patient cooperation.

Types of Otoacoustic Emissions

There are several forms of otoacoustic emissions. Each type measures cochlear function differently and is selected based on purpose, whether for screening or deeper diagnostic assessment. These variations can help clarify how audiologists interpret inner ear health.

Transient-Evoked OAE (TEOAE)

TEOAEs are responses triggered by short clicks or tone bursts. They evaluate a broad frequency range of cochlear function, making them ideal for universal newborn hearing screening programs. If emissions are present, cochlear outer hair cells are likely healthy across those frequencies. Absence may indicate fluid in the middle ear, wax blockage, or potential sensorineural hearing loss.

Distortion Product OAE (DPOAE)

DPOAEs arise when the ear is stimulated with two tones of slightly different frequencies. The cochlea generates a third signal (the “distortion product”) that the microphone detects. This test is widely used in clinical diagnostics and ototoxicity monitoring, as it can assess specific frequency regions more precisely than TEOAEs. Audiologists often use DPOAEs to detect early changes in cochlear status before noticeable hearing loss occurs.

Spontaneous OAE (SOAE)

SOAEs occur without external sound stimulation. Around 30–70% of individuals with normal hearing generate them naturally. The presence of SOAEs can indicate a healthy cochlea, but because they don’t appear in everyone, they are not typically used alone for diagnosis. Instead, they support other OAE findings.

Stimulus Frequency OAE (SFOAE)

SFOAEs use a continuous pure tone both for stimulation and measurement. They offer detailed insight into the cochlea’s mechanical tuning, but due to testing complexity, they’re less common in routine practice. When used, they may help clinicians study subtle cochlear function or specific frequency responses.

When OAE Tests Are Recommended

OAE testing is used in a variety of situations where quickly and objectively assessing cochlear function is important. Common scenarios include:

• Newborn Hearing Screening: Most universal newborn hearing screening programs in Canada use OAEs. Early detection ensures timely intervention, which is critical for speech and language development.
• Pediatric Screening: Children who can’t reliably complete standard hearing tests, such as pure-tone audiometry, benefit from OAEs. This includes children with developmental delays, cognitive impairments, or behavioral challenges.
• Ototoxicity Monitoring: Certain medications, like chemotherapy drugs or high-dose antibiotics, can damage inner ear hair cells. OAE testing helps detect early changes before noticeable hearing loss occurs.
• Difficult-to-Test Populations: OAEs are ideal for infants, ICU or comatose patients, or anyone who cannot respond behaviorally to sound.

The test, which helps in identifying potential hearing issues early, allows clinicians to provide interventions (hearing aids, therapy, or medical management) at the earliest stage, improving long-term outcomes.

What to Expect During the Test

The OAE test is painless, non-invasive, and quick. Here’s a typical experience:

1. The audiologist gently inserts a small probe with a speaker and microphone into the ear canal.
2. The probe delivers soft clicks or tone bursts to stimulate the cochlea.
3. The probe records faint echoes (OAEs) produced by the cochlea in response.
4. No active response is needed. Infants, children, or adults can simply sit or lie still.

The test usually lasts 5–15 minutes per ear. To ensure accurate results, the ear canal should be clean and free of wax. The audiologist may advise avoiding loud noises before the test and ensuring the patient remains quiet during measurement.

Understanding OAE Results

Results are straightforward but must be interpreted in context:

PASS (Present OAEs) indicates normal or near-normal cochlear function. REFER (Absent OAEs) suggests there may be a potential problem such as middle ear fluid, wax blockage, infection, or sensorineural hearing loss.

Follow-up testing, such as ABR or tympanometry, may be recommended.

While OAEs are highly sensitive to cochlear function, they do not measure auditory nerve or brain pathways. Therefore, a “refer” result doesn’t automatically mean permanent hearing loss but signals that further evaluation is needed.

Limitations of the OAE Test

While OAE testing is highly effective for screening and assessing cochlear function, it has some limitations:

• Doesn’t Assess the Entire Auditory Pathway: OAEs measure outer hair cell function in the cochlea but do not evaluate the auditory nerve or central auditory processing. Disorders such as auditory neuropathy may go undetected.
• Cannot Detect All Hearing Loss: Some forms of sensorineural or retrocochlear hearing loss, especially those affecting the auditory nerve or brainstem, require additional tests for accurate diagnosis.
• Middle Ear Issues Can Interfere: Ear canal obstructions, fluid, or infections can block sound transmission, resulting in absent OAEs even if the cochlea is healthy.
• Environmental Factors: Background noise or patient movement can affect the measurement, particularly in infants or uncooperative patients.

Because of these limitations, OAEs are often paired with other tests — such as tympanometry, ABR, or pure-tone audiometry — for a complete assessment.

OAE vs Other Hearing Tests

OAE tests are part of a larger suite of hearing assessments. Here’s how they compare:

This table illustrates why OAEs are ideal as a first-line screening tool: they are quick, objective, and non-invasive.

Who Performs the OAE Test & Where to Get One

OAE tests are typically performed by audiologists or trained hearing healthcare professionals. They are available in a variety of settings, like hospitals and audiology clinics.

Most maternity wards include OAE screening as part of universal newborn hearing screening programs. In clinics, children and adults can schedule diagnostic or follow-up testing. Patients with suspected middle ear or cochlear problems may see an ENT (Ear, Nose, and Throat) specialist.

Additionally, specialized hearing centers often provide monitoring for ototoxic medications, ongoing cochlear health assessments, and detailed diagnostic evaluations.

For patients with tinnitus or suspected cochlear abnormalities, OAEs are often part of a broader hearing evaluation. Audiologists for tinnitus ensure proper probe placement, verify that the ear canal is clear, and interpret results in the context of overall auditory health.

Why Early Hearing Screening Matters

Early hearing detection is critical for lifelong communication and development. For infants and young children, the first months of life are a sensitive period for speech and language acquisition. Detecting hearing issues promptly allows for interventions, such as hearing aids, cochlear implants, or therapy.

OAE testing is particularly valuable in populations exposed to noise or ototoxic medications. Regular monitoring with OAEs can detect subtle changes in cochlear function before noticeable hearing loss occurs, allowing clinicians to adjust treatments or implement preventive measures.

Even for older children and adults, early identification of hearing problems supports better academic, social, and occupational outcomes. OAE tests help ensure patients receive the right care at the right time.

Conclusion

The Otoacoustic Emissions (OAE) test is a fast, non-invasive, and objective way to assess cochlear function. Its ability to detect subtle changes in the outer hair cells of the inner ear makes it an essential tool in newborn hearing screening, pediatric assessments, and monitoring for ototoxicity.

While OAEs do not evaluate the entire auditory pathway and may need complementary tests for a complete diagnosis, they remain the first-line choice for screening infants, non-verbal patients, and individuals who cannot participate in behavioral hearing tests.